T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NE
1801
DELISTED
Noble Corporation
NE
| $734K | ﹤0.01% |
89,118
+48,800
| +121% | +$465K |
|
1802
Boot Barn
BOOT
$4.87B
| $733K | ﹤0.01% |
85,070
+3,000
| +4% | +$23.8K |
|
1803
Fulton Financial
FULT
$4.67B
| $732K | ﹤0.01% |
54,206
+950
| +2% | +$13K |
|
1804
MKS Inc
MKSI
$20.7B
| $730K | ﹤0.01% |
16,953
| – | – |
|
1805
Lexicon Pharmaceuticals
LXRX
$1.04B
| $728K | ﹤0.01% |
50,719
+1,620
| +3% | +$22K |
|
1806
Tetra Tech
TTEK
$9.09B
| $721K | ﹤0.01% |
117,175
+50
| +0% | +$299 |
|
1807
First Merchants
FRME
$2.72B
| $717K | ﹤0.01% |
28,768
| – | – |
|
|
UMPQ
1808
DELISTED
Umpqua Holdings Corp
UMPQ
| $716K | ﹤0.01% |
46,254
+89
| +0.2% | +$1.39K |
|
1809
MasTec
MTZ
$22.6B
| $712K | ﹤0.01% |
31,900
-7,400
| -19% | -$164K |
|
|
HW
1810
DELISTED
Headwaters Inc
HW
| $712K | ﹤0.01% |
39,700
| – | – |
|
1811
EnerSys
ENS
$6.81B
| $711K | ﹤0.01% |
11,950
+100
| +0.8% | +$5.9K |
|
|
NEWS
1812
DELISTED
NewStar Financial, Inc.
NEWS
| $711K | ﹤0.01% |
84,436
-27,155
| -24% | -$242K |
|
1813
SouthState Bank Corp
SSB
$10.8B
| $710K | ﹤0.01% |
10,429
-890
| -8% | -$61.1K |
|
1814
Mueller Industries
MLI
$15.1B
| $709K | ﹤0.01% |
89,000
+10,400
| +13% | +$80.4K |
|
1815
GATX Corp
GATX
$6.34B
| $703K | ﹤0.01% |
15,978
+40
| +0.3% | +$1.83K |
|
1816
Associated Banc-Corp
ASB
$6.07B
| $701K | ﹤0.01% |
40,860
+279
| +0.7% | +$4.96K |
|
1817
Stock Yards Bancorp
SYBT
$2.64B
| $701K | ﹤0.01% |
24,841
-1
| -0% | -$27 |
|
|
BGG
1818
DELISTED
Briggs & Stratton Corp.
BGG
| $701K | ﹤0.01% |
33,100
+9,900
| +43% | +$214K |
|
1819
Columbia Sportswear
COLM
$2.88B
| $699K | ﹤0.01% |
12,142
| – | – |
|
1820
Rambus
RMBS
$10.8B
| $698K | ﹤0.01% |
57,800
| – | – |
|
|
HRC
1821
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $697K | ﹤0.01% |
13,817
-1,600
| -10% | -$80.6K |
|
|
S
1822
DELISTED
Sprint Corporation
S
| $697K | ﹤0.01% |
153,960
-64,200
| -29% | -$238K |
|
|
TLN
1823
DELISTED
Talen Energy Corporation
TLN
| $693K | ﹤0.01% |
51,120
-18,800
| -27% | -$230K |
|
|
PKY
1824
DELISTED
Parkway, Inc.
PKY
| $692K | ﹤0.01% |
41,353
-9,300
| -18% | -$154K |
|
|
CAB
1825
DELISTED
Cabela's Inc
CAB
| $689K | ﹤0.01% |
13,756
+8
| +0.1% | +$398 |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.